Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome associated with increased cancer susceptibility. The X-linked form is due to mutations in the DKC1 gene encoding dyskerin, a nucleolar protein predicted to be involved in rRNA processing and associated with the telomerase complex. Available evidence suggests the pathology of DC is due to telomerase defects. We have used the inducible Cre/ loxP system to produce deletions in the murine Dkc1 gene in early embryogenesis. A large deletion lacking exons 12 -15 and a small deletion lacking only the last exon, were produced. We found both deletions showed a parent-of-origin effect with 100% embryonic lethality when the mutation occurred on the maternal Dkc1. Embryonic analysis at day E7.5 and E9.5 showed no male embryos carrying either deletion whereas females with maternally derived deletions died around day E9.5, with degeneration of the extra embryonic tissue, in which the paternal X-chromosome is inactivated. Female mice carrying the deletion in the paternally derived Dkc1 show extreme skewing of X-inactivation with the wild type Xchromosome active in all cells. Since mice with no telomerase are viable in the first generations the lethality we observe is unlikely to be due to the effects of mutated dyskerin on telomerase activity.
Dyskerin is a 58 kDa protein that is associated with H/ ACA box snoRNAs in nucleolar RNP particles responsible for pseudouridylation of rRNA molecules (Lafontaine et al., 1998; Spedaliere et al., 2000) . It is also part of the telomerase complex responsible for maintenance of the telomere repeats at the ends of chromosomes (Mitchell et al., 1999b) . It is not known to what extent the pathology of DC and its associated increased susceptibility to cancer is due to defective rRNA processing or defective telomere maintenance. Mitchell et al. (1999b) found telomerase RNA was unstable in DC cell lines and failed to detect abnormal rRNA processing. The finding of very short telomeres in DC patients (Mitchell et al., 1999b; Vulliamy et al., 2001b) and the discovery that a rare autosomal dominant form of DC is due to mutations in telomerase RNA (hTR) (Vulliamy et al., 2001a) support the notion that defects in telomere maintenance underlie the DC phenotype. Moreover the recent finding of hTR mutations in some cases of aplastic anemia (Vulliamy et al., 2002) and the expression of telomerase in most cancer cells (Prescott and Blackburn, 1999) , place abnormalities in the telomere maintenance pathway in a focal position in our understanding of inherited and acquired anemias and their associated malignancies.
We set out to use homologous recombination in mice to specifically target the murine Dkc1 locus. Knockout mice lacking telomerase RNA (mTR 7/7 ) have been well studied. Such mice are asymptomatic in early generations but show a variety of abnormalities including impaired wound healing, anemia and susceptibility to cancer in later generations (Blasco et al., 1997) . It has been noted that the spectrum of abnormalities is similar in DC patients (Marciniak et al., 2000) . This generation effect is presumed to be due to telomere shortening from one generation to the next, laboratory mouse strains having longer telomeres than either humans or wild mice (Hemann and Greider, 2000) . We reasoned that effects of Dkc1 gene mutation seen in early generations would not be due to impaired telomerase function and therefore the murine system would be useful to dissect out the alternate roles of dyskerin in rRNA processing and telomere maintenance.
The constructs used are shown in Figure 1 . Both use a promoterless Neo gene that is targeted to the 3' noncoding region of the Dkc1 gene and two loxP elements bordering the required deletion breakpoints. DC1 is designed to delete exons 12 -15, removing the C-terminal 124 amino acids of the protein while DC7 removes the last exon, which encodes the C-terminal 21 amino acids and mimics a deletion found in a patient with DC. This approach is useful when targeting Xlinked genes that may be important during embryonic development, since direct knockouts would impair the growth of the recombined ES cells and jeopardize germline transmission. Chimeric mice were obtained and bred to produce mice heterozygous, hemizygous and homozygous for the floxed Dkc1 alleles. All mice produced offspring carrying the floxed Dkc1 alleles in the ratios expected for X-linked inheritance. Mice with a floxed Dkc1 allele were healthy and indistinguishable from their wild type litter mates, showing that the presence of the Neo cassette and the intronic loxP elements did not impair normal development. To generate the deletions mice containing floxed Dkc1 genes were bred with cre +/7 mice which have been shown to efficiently mediate the excision of sequences bound by two loxP sites in early embryogenesisprobably at the two to four cell stage (Lakso et al., 1996; Mao et al., 1999) . Figure 2 shows the genotypes of the offspring expected and obtained from the crosses. For both of the deletion strains double transgenic mice carrying the cre and the Dkc1 D allele were only born from crosses where the floxed allele was paternal (Dkc1 Dp/+ , Figure 2a - 
c). Thus only Dkc1
D/+ females were obtained, which were unable to pass the deletion on to the next generation of mice ( Figure 2c ). The lack of double transgenic offspring from crosses of a Dkc1 lox/lox female with a cre +/7 male suggests that a maternally derived Dkc1 D (Dkc1 Dm/+ ) allele is embryonic lethal for both the male and female embryos. Results were identical for both the DC1 and DC7 mouse strains. Similar results were obtained (although Cre mediated gene deletion was less efficient) when Dkc1 lox mice were bred with mice that express Cre under the control of the adenoviral EIIa promoter (data not shown). Embryonic lethality was identical when the breeding was performed in a C57BL/6 or a 129SV genetic background. Thus the results are intrinsic to the Dkc1 gene deletion, independent of the mouse line used to express Cre in early embryogenesis and not influenced by genetic background.
To investigate the time and cause of embryonic lethality we analysed embryos at different stages of development from a cross of a Dkc1 lox/lox female with a cre +/7 or cre +/+ male ( Figure 2d ). All embryos appeared normal until day E7.5. Thereafter about one third (cre +/7 father) or all (cre +/+ father) Figure 1 Cre/loxP mediated deletion of mouse Dkc1. (a) Genomic structure of the wild-type (Wt) Dkc1 locus. The loxP sites were introduced by homologous recombination in murine embryonic stem (ES) cells using promoter trap targeting vectors. In the targeting constructs the Neomycin phosphotransferase (Neo) gene without promoter sequences was inserted into the 3' untranslated region of Dkc1. loxP cassettes flanked by BamHI and XbaI sites were prepared by annealing the two oligonucleotides 5'-CCTCTAGAGGATCCATAACTTCGTATAATGTAT GCTATACGAAGTTATTCTAGACC-3' and 5'-GGTCTAGAA-TAACTTCGTATAGCATACATTATACGAAGTTATGGATC-CTCTAGGG-3'. loxP sites were cloned into naturally occurring XbaI sites in introns 11 and 14 and into a StuI site in the 3' untranslated region. Neo driven through an internal ribosomal entry site (IRES) is only expressed when the targeting construct integrates into a gene expressed in ES cells. Out of 56 neomycin resistant clones 5 showed homologous recombination using the DC1 trap targeting vector, and out of 34 neomycin resistant clones transfected with the DC7 construct 6 were homologously recombined. Cre mediated DNA excision between the introduced loxP sites was obtained in DC1 and DC7 offspring from mice carrying floxed Dkc1 allele with mice expressing the Cre recombinase under the adenoviral EIIa promoter (Lakso et al., 1996) ). Cre mediated recombination occurs in the very early embryo prior to implantation (Lakso et al., 1996; McDevitt et al., 1997) . DDC1 and DDC7 show the Dkc1 loci after Cre mediated excision of the floxed DNA sequences. Grey boxes show coding exons; empty boxes represent noncoding exonic sequences. Mpp1 is the murine major palmitoylated protein p55 gene. RI stands for EcoRI. PS shows the genomic DNA probe used for Southern blotting. In DC1 Cre mediated loxP recombination deletes DNA sequences encompassing exons 12 -15, whereas in DC7 the DNA deletion results in the deletion DNA containing exon 15. Initial experiments were performed in a mixed 129SV/ C57BL/6 genetic background and later confirmed in a 129SV N510 and C57BL/6 N56 background. , Dkc1 lox/lox ), and the DDC alleles (Dkc1) for both the DC1 and DC7 mouse strains. Sp stands for spleen, Th for thymus and BM for bone marrow Targeted disruption of Dkc1 J He et al embryos became developmentally arrested and showed apoptotic nuclei within the trophectoderm, while yolk sac, blood islands, and alantois seemed to develop normally. At day E8.5 and E9.5 degeneration within the trophectoderm became more extensive, the affected embryos were visibly smaller, failed to show signs of axial rotation and appeared morphologically disorganized (Figure 3a -c) . At day E12.5 most of the affected embryos were resorbed. The fate of embryos from the DC1 and DC7 lines was similar. The genotype of embryos was determined by PCR for the cre gene and for the Y-chromosome marker Zfy-1 (Figure 2d) . No E7.5 day male embryos were found that had inherited the cre gene, suggesting that development of these embryos was arrested at an even earlier stage. The failure of females to develop normally when the deletion is on the maternal X-chromosome is most likely due to breakdown of extraembryonic tissues in which X-inactivation is imprinted to exclusively inactivate the paternal X-chromosome (Harper et al., 1982) . Dkc1 D/+ females carried a fully deleted Dkc1 allele in every tissue examined (Figures 1b and 3c) . Peripheral blood values, weight and physical appearance of Dkc1 D/+ animals were monitored over 12 months (DC1 n=5, DC7 n=5). At the end of the observation period necropsy and histological examination of bone marrow, gut, heart, spleen, kidney, liver and lung was performed in two Dkc1 D/+ and two Dkc1 lox/+ animals of each DC strain and two Dkc1 +/+ controls. Dkc D/+ mice appeared normal and were indistinguishable from mice carrying the floxed or with type Dkc1 allele in all parameters determined (data not shown). Examination of the Dkc1 D/+ females showed that all cells had inactivated the X-chromosome carrying the deleted gene. Firstly, RT -PCR from a variety of tissues showed the presence of only the wild type transcript (data not shown). Secondly, Southern blotting to examine the methylation status of two closely linked SacII sites in the Dkc1 promoter showed they were completely unmethylated in the wild type gene, as would be expected if it was active in all cells (Figure 3c ). We deduce that cells produced by random X-inactivation of the X chromosome carrying the wild type allele (and expressing only truncated forms of dyskerin) had a significant growth disadvantage or did not survive.
Sequence comparisons suggest dyskerin is the active pseudoridylate synthase (Heiss et al., 1998) . It is one component of snoRNP particles where it associates with H/ACA snoRNAs and is involved in the pseudouridylation of specific residues of nascent rRNA molecules during rRNA processing. Dyskerin associates with and stabilizes hTR (which in all vertebrates bears an H/ACA motif) (Mitchell et al., 1999a) . The reason for and the extent of the connection between these seemingly separate pathways is not at all clear. Our results show that targeted disruption of the Dkc1 gene produces embryonic lethality. In the case of the large deletion in the DC1 strain this result is not surprising since homologous proteins have been shown to be essential in yeast (Cadwell et al., 1997) and Drosophila (Giordano et al., 1999) . The small deletion, however, was designed to produce a truncated dyskerin protein similar to that found in a DC patient where the mutation involved a 3' end deletion removing the last exon of the gene. The most likely explanation is that the C-terminus of the truncated human DKC protein differs from the C-terminus of the DDC7 protein, because in the human patient the last 22 amino acids of dyskerin were replaced by the 12 amino acids translated from the last intron before the first stop codon (Vulliamy et al., 1999) whereas in the DC7 the C-terminal 21 amino acids are replaced by 35 different amino acids translated from the last mouse intron. An alternative possibility is that during murine embryogenesis in contrast to human embryogenesis a fully functional DKC protein is essential. We are currently testing this possibility by introducing a hypomorphic point mutation into the murine Dkc1 locus. Interestingly yeast mutants that abolish pseudouridylation are not completely inviable (Zebarjadian et al., 1999) unlike null mutations. These mutants cause growth impairment, in the context of mammalian development such impairment may cause lethality. We note that none of the DKC1 mutations found so far to cause DC affects any of the residues implicated in catalytic activity, though the 121 Ser?Gly mutation causing severe disease (Hoyeraal-Hreidarsson syndrome) is within the catalytic domain (Knight et al., 1999a (Knight et al., ,b, 2001 .
In humans dyskeratosis congenita is characterized by its classical triad of abnormal skin pigmentation, dystrophic nail changes and mucosal leukoplakia. Bone marrow failure and a propensity to develop epithelial cancers are well known entities of this syndrome (reviewed in Alter and Young, 1998) . The remarkable convergence of the etiology of DC on telomerase activity either through dyskerin necessary for hTR stabilization and accumulation (X-linked form) or hTR itself (autosomal dominant) suggested that the symptoms in DC might be caused by dysfunctional telomeres in rapidly dividing cells. However, mice defective in telomerase (mTR 7/7 and Tert 7/7 mice) are viable and do not show a phenotype in early generations of inbreeding. The lack of an animal expressing a mutant dyskerin does not allow us to draw any conclusion about the effect of mutated dyskerin on telomerase at this point. However, the lethality of our DDC mice show that dyskerin in contrast to mTR (Blasco et al., 1997) or mTert (Liu et al., 2000) is essential in mouse development. In humans the X-linked form of DC has a severe phenotype and possibly also a higher propensity to develop cancer compared to the autosomal dominant form caused by hTR mutations (Alter and Young, 1998) . Whether this is due to impaired ribosome function or more drastic reduction in telomerase activity is not known. Resolution of the role of mutated dyskerin in the pathogenesis of dyskeratosis congenita awaits the development of a (Keller et al., 1999) . Genomic DNA was digested either with SacI endonuclease alone or SacI and SacII. SacII being methylation sensitive only digests when the restriction sites are unmethylated. Methylation of the promoter region, which contains two SacII sites is associated with transcriptional silencing of genes subject to X chromosome inactivation (Razin, 1998) . Lanes 1 and 2 show DNA from a Dkc1 +/ + female digested with SacI (lane 1) and digested with SacI and SacII (lane 2). Lane 3 shows DNA from thymus from a Dkc1 Dp/+ female mouse digested with SacI and lane 4 digested with SacI and SacII. Lanes 5, 6, 7 and 8 show DNA from spleen, kidney, bone marrow and brain all digested with SacI and SacII. The fragments are indicated on the right. *Indicates the fragment cut with SacII. The Southern blot was hybridized with a single copy Dkc1 intron 9 probe. In wild type females where one chromosome is inactive in each cell SacII cleaves about 60 -70% of the DNA (lower band) indicating that the inactive allele is cleaved to some extent -this probably arises because cleavage of either SacII site will give this lower band. In DNA isolated from various tissues from Dkc1 D mice SacII cut to 100% at the 5' SacII sites of the wt Dkc1 + allele (wt*) but not in the Dkc1 D+ allele (DDC1 and DDC1*) indicating that only the Dkc1 + allele is expressed. Partial cleavage of the inactivated allele is seen again in these tracks. Note that the DC1 allele (1.7 kb larger than the wt) is missing, indicating that the deletion occurred in almost every cell. Methylation analysis was only performed in the DC1 strain because the deletion in DC7 is too small to allow discrimination between Dkc1 + and Dkc1 D+ alleles mouse model whose phenotype resembles the human disease. Point mutations in highly conserved residues that are mutated in DC may produce such a model.
